Yitu Technology

Total investments

2

Average round size

34M

Portfolio companies

2

Rounds per year

0.22

Lead investments

1

Areas of investment
BiotechnologyInformation TechnologyArtificial IntelligenceMachine LearningSemiconductorBiopharma

Summary

Yitu Technology is the famous Corporate Investor, which was founded in 2012. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Shanghai.

The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017.

We can highlight the next thriving fund investment areas, such as Manufacturing, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight ThinkForce.

The current fund was established by Lin Chenxi, Zhu Long.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Yitu Technology, startups are often financed by ZhenFund. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Sequoia Capital China, IDG Capital.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
1
Rounds per year
0.22
Investments by industry
  • Artificial Intelligence (2)
  • Machine Learning (1)
  • Biotechnology (1)
  • Biopharma (1)
  • Information Technology (1)
  • Show 1 more
Investments by region
  • China (2)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
AccutarBio 06 Dec 2017 Biotechnology, Artificial Intelligence, Machine Learning, Biopharma Early Stage Venture Shanghai, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.